Broad therapeutic uses of atypical antipsychotic medications

J Neuropsychiatry Clin Neurosci

1992 • 3,756 citations

MANIC DEPRESSIVE ILLNESS

1984 • 3,013 citations

Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis

1999 • 2,382 citations

Risperidone in the treatment of schizophrenia

1994 • 1,205 citations

Does Fast Dissociation From the Dopamine D₂ Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis

2001 • 1,113 citations

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

2000 • 1,079 citations

Relationship Between Dopamine D₂ Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

2000 • 1,036 citations

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1997 • 906 citations

Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo

1997 • 756 citations

Clinical and Theoretical Implications of 5-HT₂ and D₂ Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in Schizophrenia

1999 • 706 citations

Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study

2000 • 703 citations

The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia: A Review and Meta-analysis

1999 • 698 citations

History and evolution of the monoamine hypothesis of depression.

2000 • 634 citations

Binding of antipsychotic drugs to human brain receptors

2000 • 594 citations

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

2000 • 588 citations

Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities

2000 • 588 citations

Olanzapine Versus Placebo in the Treatment of Acute Mania

1999 • 580 citations

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease

1999 • 577 citations

Manic-Depressive Illness

1991 • 573 citations

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches

2001 • 569 citations

Efficacy of Olanzapine in Acute Bipolar Mania<subtitle>A Double-blind, Placebo-Controlled Study</subtitle>

2000 • 557 citations

A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder

2000 • 530 citations

Quetiapine in Patients With Schizophrenia

1997 • 487 citations

A Double-blind, Placebo-Controlled Study of Risperidone in Adults With Autistic Disorder and Other Pervasive Developmental Disorders

1998 • 409 citations

Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder A 6-Week Placebo-Controlled Trial

1999 • 387 citations

Ziprasidone Treatment of Children and Adolescents With Tourette's Syndrome: A Pilot Study

2000 • 338 citations

Management of treatment resistance in schizophrenia

2001 • 337 citations

Treatment of Schizophrenia

1987 • 325 citations

Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia

2001 • 304 citations

Clozapine for treatment-refractory mania

1996 • 269 citations

Depressive Signs and Symptoms in Schizophrenia

1998 • 264 citations

The Effects of Clozapine on Alcohol and Drug Use Disorders Among Patients With Schizophrenia

2000 • 253 citations

Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression

1999 • 249 citations

Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial.

1998 • 244 citations

A Randomized Controlled Trial of Risperidone in the Treatment of Aggression in Hospitalized Adolescents With Subaverage Cognitive Abilities

2001 • 235 citations

Olanzapine Treatment of Children, Adolescents, and Adults with Pervasive Developmental Disorders

1999 • 220 citations

Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.

1998 • 216 citations

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

2000 • 213 citations

Clinical Outcome in a Randomized 1-Year Trial of Clozapine Versus Treatment as Usual for Patients With Treatment-Resistant Illness and a History of Mania

2003 • 193 citations

Risperidone in the treatment of affective illness and obsessive-compulsive disorder.

1995 • 165 citations

Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.

1995 • 157 citations

Clozapine Reduces Severe Self-Mutilation and Aggression in Psychotic Patients With Borderline Personality Disorder

1999 • 157 citations

Pharmacologic treatment of schizophrenia

1999 • 151 citations

The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.

2000 • 142 citations

A Double-Blind, Controlled Comparison of the Novel Antipsychotic Olanzapine versus Haloperidol or Placebo on Anxious and Depressive Symptoms Accompanying Schizophrenia

1998 • 136 citations

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

1998 • 135 citations

Treatment of schizophrenia: A clinical and preclinical evaluation of neuroleptic drugs

1993 • 132 citations

Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.

1994 • 122 citations

Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial

2001 • 117 citations

Incidence of Tardive Dyskinesia in Early Stages of Low-Dose Treatment With Typical Neuroleptics in Older Patients

1999 • 117 citations

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia

1999 • 110 citations

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics

1998 • 109 citations

An Open-Label Study of the Treatment Efficacy of Olanzapine for Tourette's Disorder

2001 • 108 citations

Tardive and withdrawal dyskinesia in autistic children: a prospective study.

1988 • 108 citations

Efficacy of Quetiapine in Parkinson's Patients With Psychosis

2000 • 104 citations

Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.

1995 • 104 citations

Long-Term Olanzapine Therapy in the Treatment of Bipolar I Disorder

2001 • 100 citations

The Effects of Olanzapine in Reducing the Emergence of Psychosis Among Nursing Home Patients With Alzheimer's Disease

2001 • 98 citations

Olanzapine in treatment-resistant bipolar disorder

1998 • 98 citations

PET Evidence That Loxapine Is an Equipotent Blocker of 5-HT₂and D₂Receptors: Implications for the Therapeutics of Schizophrenia

1997 • 96 citations

Ziprasidone in the Short-Term Treatment of Patients with Schizoaffective Disorder: Results from Two Double-Blind, Placebo-Controlled, Multicenter Studies

2001 • 96 citations

The role of typical and atypical antipsychotic medications in the management of agitation and aggression.

1999 • 95 citations

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis

2000 • 93 citations

Behavioural Problems Associated With Dementia

1999 • 92 citations

Antipsychotic Medications and the Elderly

2001 • 92 citations

Risperidone in the Treatment of Disorders with a combined Psychotic and Depressive Syndrome - A Functional Approach

1992 • 91 citations

Short-term effects of olanzapine in Huntington disease.

2001 • 90 citations

Olanzapine Response in Psychotic Depression

1999 • 89 citations

Quetiapine fumarate (Seroquel(R)): A new atypical antipsychotic

1999 • 89 citations

In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

1999 • 87 citations

Treatment of nonpsychotic relatives of patients with schizophrenia: four case studies

1999 • 87 citations

Older Patients With Schizophrenia: Challenges in the Coming Decades

1999 • 85 citations

Quetiapine (Seroquel) in the Treatment of Psychosis in Patients With Parkinson's Disease

1998 • 84 citations

Clozapine reduces violence and persistent aggression in schizophrenia.

1998 • 84 citations

The Efficacy and Safety of Clozapine Versus Chlorpromazine in Geriatric Schizophrenia

1999 • 82 citations

Long-term risperidone treatment in bipolar disorder

1997 • 80 citations

Olanzapine in the treatment of hallucinosis in idiopathic parkinson's disease: a cautionary note

1998 • 80 citations

Olanzapine for Psychosis in Patients With Parkinson's Disease With and Without Dementia

1999 • 77 citations

Aging of the human corpus callosum: magnetic resonance imaging in normal volunteers

1991 • 64 citations

Sexuality and Serious Mental Illness

2013 • 63 citations

Risperidone in levodopa‐induced psychosis in advanced parkinson's disease: An open‐label, long‐term study

1997 • 62 citations

Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study.

1998 • 53 citations

MANAGEMENT OF PSYCHOTIC, TREATMENT-RESISTANT DEPRESSION

1996 • 49 citations

Treatment of elderly institutionalized bipolar patients with clozapine.

1997 • 49 citations

Clinical Experience with Quetiapine in Elderly Patients with Psychotic Disorders

2000 • 47 citations

New treatments for bipolar disorder: the role of atypical neuroleptic agents.

2000 • 45 citations

Schizophrenia and mood disorders : the new drug therapies in clinical practice

1999 • 42 citations

Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study.

2000 • 41 citations

Management of psychotic aspects of Parkinson's disease.

1999 • 41 citations

Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.

1999 • 41 citations

Three-year follow-up of older schizophrenics: Extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratio

1991 • 40 citations

Use of Risperidone in Psychosis Associated With Huntington's Disease

1998 • 39 citations

What Makes an Antipsychotic ‘Atypical’?

1997 • 37 citations

Remission of Self-Mutilation in a Patient with Borderline Personality during Risperidone Therapy

1997 • 36 citations

Quetiapine as an Alternative to Clozapine in the Treatment of Dopamimetic Psychosis in Patients with Parkinson's Disease

1999 • 35 citations

Treatment of bipolar mixed state with olanzapine.

1999 • 32 citations

Quetiapine for <scp>l</scp> -dopa–induced psychosis in PD

2000 • 31 citations

Efficacy and Tolerability of Olanzapine in Elderly Patients with Psychotic Disorders: A Prospective Study

2000 • 22 citations

Quetiapine and risperidone in outpatients with psychotic disorders: Results of the QUEST trial

1999 • 16 citations

Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine

2000 • 15 citations

The study of olanzapine plus fluoxetine in treatment-resistant major depressive disorder without psychotic features

2000 • 13 citations

Inpatient Treatment of Severe Disruptive Behaviour Disorders with Risperidone and Milieu Therapy

2000 • 11 citations

Treatment of Borderline Personality Disorder

1999 • 11 citations

Olanzapine: Acute and long-term efficacy in bipolar I patients

2000 • 6 citations

New treatments of bipolar disorder

1999 • 6 citations

Comprehensive disease management for schizophrenia

2000 • 5 citations

An overview of the efficacy and safety of rapid-acting intramuscular ziprasidone

2000 • 4 citations

Safety of the novel antipsychotic olanzapine in the treatment of bipolar I disorder

2000 • 4 citations

Clinical Improvement and tolerability is maintained long term in elderly patients with psychotic disorders treated with quetiapine

1999 • 3 citations

New treatments for bipolar disorder

2002 • 2 citations

Risperidone in children with significant conduct problems and subaverage intellectual functioning

2001 • 1 citations

Seroquel does not elevate prolactin levels in adolescents with selected psychotic disorders

2000 • 1 citations